Ocular Surface

Papers
(The H4-Index of Ocular Surface is 30. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Corrigendum to “New insights into lacrimal gland anatomy using 7T MRI and electron microscopy: Relevance for lacrimal gland targeted therapies and bioengineering” [Ocul. Surf. 30 (October 2023) 204–21149
Editorial Board100
Long term study of topical interferon α-2b eye drops as primary treatment of ocular surface squamous neoplasia80
Biology and medicine on ocular surface restoration: Advancements and limits of limbal stem cell deficiency treatments77
Atypical microbial keratitis63
Effects of Panretinal photocoagulation on the ocular surface and tear film61
Endogenous TSG-6 modulates corneal inflammation following chemical injury58
Economic burden of keratitis patients with inpatient care: a nationwide, multicenter registry study56
Safety of subconjunctival injection of mesenchymal stromal cells in persistent corneal epithelial disease – A phase 1b clinical trial53
Development and validation of a method to generate phenol red thread tests51
Monkeypox and ocular implications in humans47
Dry eye disease and proteomics44
Readership awareness series – Paper 10: Open Access Publishing43
A prospective self-controlled study on the alterations of the ocular surface and conjunctival transcriptomic profile associated with prolonged exposure to video display terminals43
Epidemiology and risk factors for the development of cicatrizing conjunctivitis in chronic ocular graft-versus-host disease43
Effects of age on lacrimal gland bioactive lipids42
Predatory bacteria can reduce Pseudomonas aeruginosa induced corneal perforation and proliferation in a rabbit keratitis model42
Chronic inflammation as a proposed risk factor for ocular surface squamous neoplasia40
Tear film changes in symptomatic versus asymptomatic video display terminal users following computer challenge test40
Impact of digital screen use and lifestyle factors on dry eye disease in the paediatric population40
Editorial Board38
Organotypic culture model of mouse meibomian gland as a screening platform for risk factors related to meibomian gland dysfunction38
Herpes simplex virus, varicella-zoster virus and cytomegalovirus keratitis: Facts for the clinician37
Allogeneic mesenchymal stem cell therapy for dry eye disease in patients with Sjögren's syndrome: A randomized clinical trial36
A pilot randomized controlled trial of topical androgen treatment in dry eye36
New disposable esthesiometer (KeraSenseⓇ) to improve diagnosis and management of neurotrophic keratitis34
The clinical outcomes of minor salivary gland transplantation for severe dry eye disease secondary to chronic Stevens-Johnson syndrome33
Diagnostic performance and optimal cut-off values for tear film lipid layer grading and thickness in dry eye disease: An investigator-masked, randomised crossover study32
Modulating the tachykinin: Role of substance P and neurokinin receptor expression in ocular surface disorders31
Corneal gene therapy: Structural and mechanistic understanding31
Interdisciplinary management of belantamab mafodotin-associated ocular toxicity in clinical practice30
0.044538974761963